G.C. Viscomi

627 total citations
23 papers, 502 citations indexed

About

G.C. Viscomi is a scholar working on Molecular Biology, Spectroscopy and Organic Chemistry. According to data from OpenAlex, G.C. Viscomi has authored 23 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Spectroscopy and 5 papers in Organic Chemistry. Recurrent topics in G.C. Viscomi's work include Chemical Synthesis and Analysis (4 papers), Analytical Chemistry and Chromatography (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). G.C. Viscomi is often cited by papers focused on Chemical Synthesis and Analysis (4 papers), Analytical Chemistry and Chromatography (4 papers) and Pneumocystis jirovecii pneumonia detection and treatment (4 papers). G.C. Viscomi collaborates with scholars based in Italy, United States and Slovakia. G.C. Viscomi's co-authors include Corrado Blandizzi, Cecilia Renzulli, Carmelo Scarpignato, Fiorella Calanni, Miriam Barbanti, A. S. Verdini, Fabrizia Grepioni, Dario Braga, Saul Lande and A Marzo and has published in prestigious journals such as Gastroenterology, Journal of Chromatography A and Experimental Cell Research.

In The Last Decade

G.C. Viscomi

22 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.C. Viscomi Italy 13 166 92 82 72 56 23 502
Andrés Guerrero United States 12 284 1.7× 51 0.6× 35 0.4× 54 0.8× 15 0.3× 17 522
Abhinav Kumar United Kingdom 14 423 2.5× 47 0.5× 114 1.4× 141 2.0× 59 1.1× 38 791
Paul Kowalczyk United States 9 279 1.7× 32 0.3× 90 1.1× 71 1.0× 57 1.0× 14 685
Daniel Muthas Sweden 16 305 1.8× 181 2.0× 64 0.8× 17 0.2× 72 1.3× 33 863
Kamalendra Singh United States 17 465 2.8× 85 0.9× 109 1.3× 23 0.3× 26 0.5× 34 1.3k
Christopher T. Lemke Canada 15 291 1.8× 36 0.4× 58 0.7× 30 0.4× 53 0.9× 27 647
S. Padma India 17 135 0.8× 49 0.5× 125 1.5× 24 0.3× 41 0.7× 35 648
J. Kevin Judice United States 14 411 2.5× 23 0.3× 132 1.6× 40 0.6× 23 0.4× 16 919
Jean L. Whittingham United Kingdom 17 604 3.6× 22 0.2× 39 0.5× 59 0.8× 168 3.0× 27 914
Fátima Pereira de Souza Brazil 14 260 1.6× 53 0.6× 158 1.9× 18 0.3× 21 0.4× 49 621

Countries citing papers authored by G.C. Viscomi

Since Specialization
Citations

This map shows the geographic impact of G.C. Viscomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.C. Viscomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.C. Viscomi more than expected).

Fields of papers citing papers by G.C. Viscomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.C. Viscomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.C. Viscomi. The network helps show where G.C. Viscomi may publish in the future.

Co-authorship network of co-authors of G.C. Viscomi

This figure shows the co-authorship network connecting the top 25 collaborators of G.C. Viscomi. A scholar is included among the top collaborators of G.C. Viscomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.C. Viscomi. G.C. Viscomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blandizzi, Corrado, G.C. Viscomi, A Marzo, & Carmelo Scarpignato. (2014). Is generic rifaximin still a poorly absorbed antibiotic? A comparison of branded and generic formulations in healthy volunteers. Pharmacological Research. 85. 39–44. 30 indexed citations
2.
Scarpignato, Carmelo, Corrado Blandizzi, & G.C. Viscomi. (2014). Impact of crystal polymorphism on the systemic bioavailability of rifaximin, an antibiotic acting locally in the gastrointestinal tract, in healthy volunteers. Drug Design Development and Therapy. 9. 1–1. 40 indexed citations
3.
Calanni, Fiorella, Cecilia Renzulli, Miriam Barbanti, & G.C. Viscomi. (2014). Rifaximin: beyond the traditional antibiotic activity. The Journal of Antibiotics. 67(9). 667–670. 79 indexed citations
4.
Braga, Dario, et al.. (2012). The structure–property relationship of four crystal forms of rifaximin. CrystEngComm. 14(20). 6404–6404. 28 indexed citations
5.
Viscomi, G.C., Marco Barbanti, Fabrizia Grepioni, et al.. (2008). Crystal forms of rifaximin and their effect on pharmaceutical properties. CrystEngComm. 10(8). 1074–1074. 47 indexed citations
6.
Ratta, Marina, Antonio Curti, Miriam Fogli, et al.. (2000). Efficient presentation of tumor idiotype to autologous T cells by CD83+ dendritic cells derived from highly purified circulating CD14+ monocytes in multiple myeloma patients. Experimental Hematology. 28(8). 931–940. 31 indexed citations
7.
Viscomi, G.C., Guido Antonelli, Bruno Coutard, et al.. (1999). Antigenic Characterization of Recombinant, Lymphoblastoid, and Leukocyte IFN-alpha by Monoclonal Antibodies. Journal of Interferon & Cytokine Research. 19(4). 319–326. 8 indexed citations
8.
Viscomi, G.C., et al.. (1998). Variations in the Interferon-Inducing Capacity of Sendai Virus Subpopulations. Journal of Interferon & Cytokine Research. 18(6). 399–405. 9 indexed citations
9.
Simeoni, Eleonora, F. Dianzani, G.C. Viscomi, et al.. (1997). Clinical Relevance of Antibodies to Interferon in Hepatitis C Patients. Pharmacy and Pharmacology Communications. 3(1). 43–48. 1 indexed citations
10.
Viscomi, G.C.. (1997). Structure-activity of type I interferons. Biotherapy. 10(1). 59–86. 21 indexed citations
11.
Troiano, Leonarda, Daniela Monti, Walter Malorni, et al.. (1995). Sendai Virus and Herpes Virus Type 1 Induce Apoptosis in Human Peripheral Blood Mononuclear Cells. Experimental Cell Research. 218(1). 63–70. 59 indexed citations
12.
Viscomi, G.C., et al.. (1995). Human leukocyte interferon alpha: Structure, pharmacology, and therapeutic applications. Medicinal Research Reviews. 15(5). 445–478. 25 indexed citations
13.
Viscomi, G.C., et al.. (1992). Purification of recombinant human interferon-β by immobilized antisense peptides. Journal of Chromatography A. 600(2). 235–242. 22 indexed citations
14.
Viscomi, G.C., et al.. (1991). Large-scale purification of the synthetic peptide fragment 163–171 of human interleukin-β by multi-dimensional displacement chromatogaphy. Journal of Chromatography A. 549(1-2). 175–184. 9 indexed citations
15.
Cardinali, F L, et al.. (1990). Scaling-up procedure from the range of milligrams to grams for the purification of amino acid derivatives in displacement chromatography. Journal of Chromatography A. 499. 37–45. 11 indexed citations
16.
Angelis, Francesco De, et al.. (1989). Fast atom bombardment mass spectrometry and selective acid hydrolysis for the analysis of partially modified retro-inverso peptide analogues. Journal of Mass Spectrometry. 18(10). 867–871. 4 indexed citations
17.
Viscomi, G.C., et al.. (1989). Preparative purification of Plasmodium falciparum circumsporozoite protein synthetic polypeptides by displacement chromatography. Journal of Chromatography A. 482(1). 99–106. 8 indexed citations
19.
Viscomi, G.C., Saul Lande, & Csaba Horváth. (1988). High-performance displacement chromatography of melanotropins and their derivatives. Journal of Chromatography A. 440. 157–164. 23 indexed citations
20.
Verdini, A. S. & G.C. Viscomi. (1985). Synthesis, resolution, and assignment of configuration of potent hypotensive retro-inverso bradykinin potentiating peptide 5a(BPP5a) analogues. Journal of the Chemical Society Perkin Transactions 1. 697–697. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026